Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I
Clinical trial NCT02702115 · TERMINATED
Trial details
- NCT number
- NCT02702115
- Sponsor
- Sangamo Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-24
- Primary completion
- 2021-11-03
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.